Hongfeng Gou
- Oncology top 10%
- Peptidase Inhibition and Analysis 12
- Pancreatic and Hepatic Oncology Research 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 7
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
- Gastroenterology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
-
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Dan CaoMei HouMing JiangYu YangYang YuYong‐Song GuanXinchuan ChenJiang Zhu
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hongfeng Gou
51 papers receiving 947 citations
Peers
Comparison fields: 5 of 91
- Oncology 447
- Cancer Research 190
- Pathology and Forensic Medicine 142
- Immunology 153
- Gastroenterology 33
Countries citing papers authored by Hongfeng Gou
This map shows the geographic impact of Hongfeng Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfeng Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfeng Gou more than expected).
Fields of papers citing papers by Hongfeng Gou
This network shows the impact of papers produced by Hongfeng Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfeng Gou. The network helps show where Hongfeng Gou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongfeng Gou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2019 | 6 | |
| 15 | 2019 | 75 | |
| 16 | 2017 | 76 | |
| 17 | 2015 | 4 | |
| 18 | 2014 | 19 | |
| 19 | 2013 | 8 | |
| 20 | 2010 | 49 |
About Hongfeng Gou
Hongfeng Gou is a scholar working on Oncology, Pathology and Forensic Medicine and Toxicology, having authored 60 papers that have together received 968 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Peptidase Inhibition and Analysis (12 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Mechanisms and Therapy (7 papers), Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (447 citations), Cancer Research (190 citations) and Pathology and Forensic Medicine (142 citations). Hongfeng Gou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Dan Cao, Mei Hou, Ming Jiang, Yu Yang, Yang Yu, Yong‐Song Guan, Xinchuan Chen, Jiang Zhu, Wei Wang and Yong Huang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.